Drug treatment services given £29m funding
Frontline drug treatment services in Scotland are to be given almost £29m funding next year.
Pain Therapeutics, Inc. today announced that it had received a $5,000,000 milestone payment from King Pharmaceuticals, Inc., its exclusive commercial partner for abuse-resistant prescription pain medications.